文献速递冠心病外科

体外循环回路添加一氧化氮在冠脉搭桥术中的心肌保护作用:随机试验

Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-10-13

这项前瞻性随机先导研究纳入60例择期行体外循环下冠状动脉旁路移植术的冠心病患者,随机分为标准体外循环组或在体外循环回路中添加40 ppm一氧化氮的改良组。主要终点为心肌肌钙蛋白I,次要终点包括CK-MB和血管活性正性肌力评分。结果显示一氧化氮组术后6小时cTnI和24小时CK-MB均显著低于对照组,术后6小时VIS也显著更低,提示体外循环回路供给一氧化氮对冠脉搭桥术具有心肌保护作用。

要点

  • 体外循环回路添加40 ppm一氧化氮可降低冠脉搭桥术后cTnI和CK-MB水平。
  • 一氧化氮组术后6小时血管活性正性肌力评分显著低于对照组。
  • 该策略可能减轻体外循环下冠脉搭桥术中的缺血再灌注损伤。

核心结论

  • 冠脉搭桥术中向体外循环回路供给一氧化氮具有心肌保护效应,并与更低的血管活性正性肌力评分及心肌特异性血标志物cTnI和CK-MB水平相关。

研究设计与样本

  • 前瞻性随机先导研究,共纳入60例计划行体外循环下冠状动脉旁路移植术的冠心病患者,随机分入标准体外循环方案组或改良方案组(术中向体外循环回路添加40 ppm一氧化氮)。

主要发现

  • 术后6小时cTnI在NO组为1.79 ± 0.39 ng/mL,对照组为2.41 ± 0.55 ng/mL(P = .001)。
  • 术后24小时CK-MB在NO组为47.69 ± 8.08 U/L,对照组为62.25 ± 9.78 U/L(P = .001)。
  • 干预后6小时血管活性正性肌力评分在NO组显著低于对照组。

临床怎么用

  • 在体外循环下冠脉搭桥术中,可考虑向体外循环回路添加40 ppm一氧化氮作为心肌保护策略,但需注意此为小样本先导研究结果。

局限性

  • 本研究为先导性随机试验,样本量较小(60例),结果需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this pilot study was to elucidate the effects of exogenous nitric oxide (NO) supply to the extracorporeal circulation circuit for cardioprotection against ischemia-reperfusion injury during coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB). METHODS: A total of 60 patients with coronary artery disease scheduled for CABG with CPB were enrolled in a prospective randomized study. Patients were allocated randomly to receive treatment according to standard or modified CPB protocol where 40-ppm NO was added to the CPB circuit during cardiac surgery. The primary endpoint was the measurement of cardiac troponin I (cTnI). The secondary end points consisted in the measurements of creatine kinase-muscle/brain fraction (CK-MB) and vasoactive inotropic score (VIS). RESULTS: NO delivered into the CPB circuit had a cardioprotective effect. The level of cTnI was significantly lower in NO-treated group compared with the control group 6 hours after surgery: 1.79 ± 0.39 ng/mL versus 2.41 ± 0.55 ng/mL, respectively (P = .001). The CK-MB value was significantly lower in NO-treated group compared with the control group 24 hours after surgery: 47.69 ± 8.08 U/L versus 62.25 ± 9.78 U/L, respectively (P = .001); and the VIS was significantly lower in the NO-treated group 6 hours after the intervention. CONCLUSIONS: NO supply to the CPB circuit during CABG exerted a cardioprotective effect and was associated with lower levels of VIS and cardiospecific blood markers cTnI and CK-MB.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kamenshchikov NO, Mandel IA, Podoksenov YK, et al. Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial. J Thorac Cardiovasc Surg. 2018. PMID: 30447958. doi:10.1016/j.jtcvs.2018.08.117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。